1900 |
Description of toxoplasma-like parasites in Java sparrows |
[246,247] |
1908 |
First description of toxoplasma-like tissue cysts in humans (as sarcosporidiosis) |
[248] |
1908 |
Description of T. gondii merozoites in gondi (first named Leishmania gondii) |
[2] |
1909 |
Introduction of the genus Toxoplasma (type species: T. gondii) |
[3] |
1923 |
First recorded case of toxoplasmosis in an 11- month-old infant with congenital hydrocephalus and microphthalmia (recognised retrospectively) |
[203,204,249] |
1928 |
First description of the tissue cyst as a persistent stage in intermediate hosts |
[205] |
1937 |
First recorded case of fatal disseminated toxoplasmosis in an adult (22-year-old) human |
[250] |
1937–39 |
Recognition of T. gondii as a causative agent of encephalomyelitis in human neonates |
[206–208] |
1939 |
Description of classic triad of symptoms of congenital toxoplasmosis in humans (retinochoroiditis, hydrocephalus, encephalitis followed by cerebral calcification) |
[208] |
1939 |
Identity of isolates from humans and animals based on biological and immunological similarities |
[6] |
1940–41 |
Recognition of T. gondii as a causative agent of acute, acquired disease in adult humans |
[250,251] |
1941–42 |
Comprehensive description of toxoplasmic encephalitis in children with acquired toxoplasmosis |
[252,253] |
1942 |
Vertical transmission recognised in humans |
[209] |
1948 |
Methylene blue dye test introduced for detection of antibodies to T. gondii (gold standard for T. gondii-specific serology in humans) |
[40] |
1951–52 |
Recognition of T. gondii as a causative agent of lymphadenopathy in humans |
[254,255] |
1952 |
Description of T. gondii as a causative agent of retinochoroiditis in humans |
[71] |
1952 |
Description of classic tetrad of symptoms of congenital toxoplasmosis in humans (retinochoroiditis, cerebral calcification, hydrocephalus or microcephalus, and psychomotor disturbances) |
[256] |
1953–54 |
First recorded case of toxoplasmic encephalitis in a patient with Hodgkin’s disease |
[257] |
1954–56 |
Hypothesis that horizontal transmission to humans may occur via tissue cysts in undercooked meat (pork) |
[258,259] |
1959 |
Serological evidence of T. gondii infections in vegetarians |
[260] |
1960 |
Discovery that tissue cysts are resistant to proteolytic enzymes |
[127,261] |
1960 |
Description of major sequelae of congenital toxoplasmosis in humans |
[262] |
1965 |
Recognition of the coccidian nature of T. gondii based on the ultrastructure of extraintestinal merozoites |
[263,264] |
1965 |
Epidemiological evidence that horizontal transmission to humans occurs via undercooked meat |
[265] |
1965 |
Hypothesis that an infectious stage of T. gondii is passed into the environment via the faeces of cats |
[9] |
1968 |
Recognition of T. gondii as a complication in patients with malignancies |
[266] |
1969 |
Identification of the oocyst of T. gondii
|
[267–273] |
1970 |
Description of the sexual phase of the life cycle in the small intestine of cats |
[270,274– 277] |
1969–72 |
Recognition of the epidemiological role of cats in the spread of T. gondii in different geographical areas |
[171,172] |
1981–82 |
First recorded cases of CNS toxoplasmosis in AIDS patients |
[278] |
1984 |
Recognition of T. gondii as an opportunistic pathogen in AIDS patients |
[102] |
1995–99 |
Largest recorded outbreak of acute toxoplasmosis in humans (100 individuals aged 6–83 years) associated with oocysts in municipal drinking water |
[69,191,279] |